# Sharma East Ind (NSE: SHARMEH) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SHARMEH · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹33 Cr, it ranks 3323rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

Its return on equity was 10.0% in FY25.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹33 Cr |
| ROE | 10.0% (FY25) |
| ROCE | 15.4% (FY25) |
| Debt to equity | 0.18 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹30 Cr | ₹1 Cr |
| FY24 | ₹19 Cr | ₹1 Cr |
| FY23 | ₹21 Cr | ₹1 Cr |
| FY22 | ₹17 Cr | ₹1 Cr |
| FY21 | ₹8 Cr | ₹1 Cr |
| FY20 | ₹16 Cr | ₹0 Cr |

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [JFL Life Scienc](https://app.pivotnow.in/stock/JFLLIFE) | ₹10.30 | ₹34 Cr | 0.2 | — |
| [Chandra Bhagat](https://app.pivotnow.in/stock/CBPL) | — | ₹33 Cr | — | — |
| [Deccan Health C](https://app.pivotnow.in/stock/DECCAN) | — | ₹32 Cr | — | — |
| [Medi-Caps](https://app.pivotnow.in/stock/MEDICAPQ) | ₹25.50 | ₹32 Cr | — | — |
| [KK Shah Hospita](https://app.pivotnow.in/stock/KKSHL) | — | ₹30 Cr | — | — |
| [Panjon](https://app.pivotnow.in/stock/PANJON) | — | ₹30 Cr | — | — |

## Questions and answers

### What is the market cap of Sharma East Ind?

Sharma East Ind's market capitalisation is ₹33 Cr (₹33 Cr) at the 22 Oct 2026 close, ranking 3323rd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Sharma East Ind?

Return on equity was 10.0% in FY25 and return on capital employed was 15.4% in FY25 (standalone figures).

### Is Sharma East Ind a debt-free company?

No. Sharma East Ind's debt-to-equity ratio was 0.18 in FY25, with total debt of ₹1 Cr.

### Who are Sharma East Ind's competitors?

The listed Pharma & Healthcare companies closest to Sharma East Ind by market cap are JFL Life Scienc, Chandra Bhagat, Deccan Health C, Medi-Caps, KK Shah Hospita and Panjon.

### Is Sharma East Ind a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Sharma East Ind's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SHARMEH against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.